Renovacor is a preclinical stage biotechnology company whose mission is to develop improved therapies for genetically derived cardiovascular diseases. The company is currently developing a gene therapy for a rare, familial form of dilated cardiomyopathy.
Market
Cardiovascular diseases
Location
Philadelphia,
PA,
USA
Coinvestors
BioAdvance, Broadview Ventures, Innogest Capital, New Leaf Venture Partners, Novartis Venture Fund